Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism

NCT ID: NCT02127840

Last Updated: 2014-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project is aimed to determine the value of synacthen infusion on the results of adrenal venous sampling in patients examined for primary aldosteronism

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We aim to compare the results of adrenal venous sampling performed without and during synacthen infusion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Aldosteronism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Synacthen

Synacthen infusion during adrenal venous sampling

Group Type EXPERIMENTAL

Synacthen infusion during adrenal venous sampling

Intervention Type DRUG

Adrenal venous sampling during Synacthen infusion

Without Synacthen

Adrenal venous sampling without Synacthen

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Synacthen infusion during adrenal venous sampling

Adrenal venous sampling during Synacthen infusion

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Inclusion Criteria: Confirmed primary aldosteronism

Exclusion Criteria: Inability to undergo unilateral adrenalectomy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Hradec Kralove

OTHER

Sponsor Role collaborator

Charles University, Czech Republic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Miroslav Solar

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jiri Ceral, MD

Role: STUDY_CHAIR

University Hospital Hradec Kralove

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Hradec Kralove

Hradec Králové, , Czechia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Miroslav Solar, MD

Role: CONTACT

+420495834739

Jiri Ceral, MD

Role: CONTACT

+420495833249

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Miroslav Solar, MD

Role: primary

+420495834739

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PAAVS1143

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Influence on Erythropoetin-level by Xenon
NCT02129400 TERMINATED PHASE3
Caffeine and Resistance Training in Older Adults
NCT06618261 ENROLLING_BY_INVITATION NA
Response to Clenbuterol in Humans
NCT03860870 COMPLETED NA